Updates

Eagle Eye - Wins further North American business

March 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Ahead of reporting its H1 on 16 March, Eagle Eye said H1 sales will be up 40% to £15.1m, of which recurring revenue (subscription fees and transactions) is 76%. Adjusted ebitda is up 50% to £3.1m. Net cash is £1.8m. New customers for the Eagle Eye AIR platform in the period included Halfords (launches in March) whilst a number of significant customer contracts moved into the transactional phase, including Woolworths in Australia, Staples US Retail and Virgin Red. Meanwhile, Eagle Eye's work with Southeastern Grocers in the U.S. has continued to progress well. Post period end, through its reseller partner Neptune Retail Solutions, it has secured further US customers including one of the largest national U.S. grocers earlier this mo ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Ergomed - Buys specialist consultancy for £25.6m

CentralNic

Eagle Eye (February 2023)

Eagle Eye (April 2021)

Eagle Eye (October 2020)

Eagle Eye (December 2019)

Eagle Eye - Moves to EBITDA profitability (August 2019)

Eagle Eye - Shares well off the 316p high; 72% recurring fees (June 2019)

Eagle Eye - Positive EBITDA expected for H2 (April 2019)

Eagle Eye (December 2018)

Eagle Eye (August 2017)

Eagle Eye (July 2017)

Eagle Eye - Strong momentum with tier 1 retailers continues (June 2017)

Eagle Eye - Coupon redemption volumes rise to 4m a month in February (May 2017)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X